PDS Biotechnology's total assets for Q3 2024 were $52.45M, a decrease of -13.30% from the previous quarter. PDSB total liabilities were $30.45M for the fiscal quarter, a 2.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.